Abstract
A divergent modular strategy for the enantioselective total synthesis of 12 naturally-occurring griseusin type pyranonaphthoquinones and 8 structurally-similar analogues is described. Key synthetic highlights include Cu-catalyzed enantioselective boration-hydroxylation and hydroxyl-directed C-H olefination to afford the central pharmacophore followed by epoxidation-cyclization and maturation via diastereoselective reduction and regioselective acetylation. Structural revision of griseusin D and absolute structural assignment of 2a,8a-epoxy-epi-4′-deacetyl griseusin B are also reported. Subsequent mechanistic studies establish, for the first time, griseusins as potent inhibitors of peroxiredoxin 1 (Prx1) and glutaredoxin 3 (Grx3). Biological evaluation, including comparative cancer cell line cytotoxicity and axolotl embryo tail inhibition studies, highlights the potential of griseusins as potent molecular probes and/or early stage leads in cancer and regenerative biology.
| Original language | English |
|---|---|
| Pages (from-to) | 7641-7648 |
| Number of pages | 8 |
| Journal | Chemical Science |
| Volume | 10 |
| Issue number | 32 |
| DOIs | |
| State | Published - 2019 |
Bibliographical note
Publisher Copyright:© 2019 The Royal Society of Chemistry.
Funding
This work was supported by National Institutes of Health grants R01 CA203257 (QBS, JST), R24 OD21479 (SRV, JST), R01 CA175105 (QBS), T32 DA016176 (YZ), the University of Kentucky College of Pharmacy, the National Center for Advancing Translational Sciences (UL1TR000117 and UL1TR001998), and the Start-up funding of Jiangsu Specially-Appointed Professor and National Natural Science Foundation of China (No. 21877062, YZ). We also thank Prof. Tyler D. McQuade (Florida State University) generously providing McQuade I NHC copper catalyst.
| Funders | Funder number |
|---|---|
| Jiangsu Specially-Appointed Professor | |
| University of Kentucky College of Pharmacy | |
| National Institutes of Health (NIH) | R24 OD21479, R01 CA203257 |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001998, UL1TR000117 |
| National Natural Science Foundation of China (NSFC) | 21877062 |
| Japan Science and Technology Agency | R01 CA175105, T32 DA016176 |
ASJC Scopus subject areas
- General Chemistry